NYSE$AHR
American Healthcare REIT Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
American Healthcare REIT Inc's Q2 2024 results were announced, and full-year 2024 guidance was increased.
American Healthcare REIT reported a GAAP net income of $2.9 million for the second quarter of 2024, a significant improvement from the net loss of $(11.9) million in the same period last year. The company also achieved a total portfolio Same-Store NOI growth of 15.7% and increased its full-year guidance for both Same-Store NOI growth and NFFO.
- Reported GAAP net income attributable to common stockholders of $0.01 per diluted share.
- Reported Normalized Funds from Operations attributable to common stockholders (“NFFO”) of $0.33 per diluted share.
- Achieved total portfolio Same-Store Net Operating Income (“NOI”) growth of 15.7%.
- Increased total portfolio Same-Store NOI growth guidance for the year ending December 31, 2024 to a revised range of 12.0% to 14.0%.
Headline financials
Revenue & EPS history
American Healthcare REIT Inc · Revenue · Quarterly
$458M
Revenue by segment
American Healthcare REIT Inc · $543M total across 4 segments · Q4 2024
- ISHC$423M—78.0%
- SHOP$73.5M—13.6%
- Outpatient Medical$33.3M—6.1%
- Triple-Net Leased$12.6M—2.3%
Forward guidance
American Healthcare REIT increased its full year 2024 Same-Store NOI growth and earnings guidance to reflect the occupancy gains and results achieved in 2024.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 11 quarterly earnings reports · overlaid with Q2 2024
+1.8%
Avg return
Earnings day
+2.2%
Avg return
5 days after
+3.9%
Avg return
30 days after
64%
7 / 11 earnings
Positive
+8.3%
Q1 2025
Best reaction
-2.1%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +4.3% | +4.1% | -4.2% | |
| Q4 2025 | -2.1% | -2.5% | -11.4% | |
| Q3 2025 | +3.0% | -0.1% | +4.6% | |
| Q2 2025 | +1.3% | +2.0% | +7.2% | |
| Q1 2025 | +8.3% | +6.1% | +10.2% | |
| Q4 2024 | -1.3% | +0.7% | +0.8% | |
| Q3 2024 | +1.2% | +2.7% | +7.1% | |
| Q2 2024 | +3.3% | +3.6% | +35.1% | |
| Q1 2024 | -0.1% | +3.5% | +6.2% | |
| Q2 2023 | +2.8% | +1.3% | -6.8% | |
| Q4 2023 | -0.8% | +3.2% | -5.9% | |
| Q3 2023 | — | — | — | |
| Q1 2023 | — | — | — | |
| Q4 2022 | — | — | — | |
| Q3 2022 | — | — | — | |
| Q2 2022 | — | — | — | |
| Q1 2022 | — | — | — | |
| Q4 2021 | — | — | — | |
| Q3 2021 | — | — | — | |
| Q2 2021 | — | — | — | |
| Q1 2021 | — | — | — | |
| Q4 2020 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — | |
| Q3 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro